GLP-1 drugs are now friendlier to needle-phobes. But do the pills still work?

Eli Lilly knows that its GLP-1 windfall comes with an end date, so it is acting now to prepare.

Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer ...

You’ve probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss ...

GLP-1 medications like Ozempic and Wegovy are used for weight loss and diabetes. Learn how they work, their costs, and potential side effects.

Weight loss medications have changed the game of health and wellness. From protein-focused private label to wellness guides, ...

Until recently, several glucagon-like peptide-1 (GLP-1) injections were in shortage. During this time, compounded versions became a more accessible option. Now, brand-name GLP-1 injections of ...

GLP-1 consumer apps can help patients stay on track but have no evidence base; clinical-grade apps can do more but are not ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic, Wegovy, ...

Research on the experimental drug petrelintide suggests it is much less likely to cause nausea and vomiting than GLP-1 drugs, ...

A new Medicare program launching July 1 broadens access to drugs like Zepbound and Foundayo, but federal annuitants need to know how the $50 copay will affect their catastrophic limits.

Experts say exponential growth in the use of drugs such as Wegovy is shifting our perception of what is attractive ...